Asia Pacific Stroke Management Market (2018 - 2024)
The Asia Pacific Stroke Management Market would witness market growth of 8.2% CAGR during the forecast period (2018 – 2024). Stroke is a medical emergency which occurs when the flow of the blood is restricted to the brain and as a result, brain cells start dying. Rise in incidence and prevalence of chronic diseases has been a major factor that is responsible for the growth of the stroke management market. Additionally, growing geriatric population, which is highly susceptible to strokes, growing diabetic population and usage of tobacco are other factors that are driving the growth of the market. However, the cost associated with the treatment and stringent government regulations pertaining to the approval of new and advances devices and drugs would limit the market growth. Asia-Pacific is the region with tremendous market potential, due to rising prevalence of strokes, which is due to growing incidence of chronic diseases and use of tobacco.
Based on Application, the market is segmented into Ischemic Stroke and Hemorrhagic Stroke. Based on Type, the market is segmented into Diagnostics and Therapeutics. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, B. Braun Melsungen Ag, Boston Scientific Corporation, Cardinal Health, Inc., Ge Healthcare, Glaxosmithkline Plc, Medtronic Plc., Siemens Aktiengesellschaft, Merck & Co., Inc., and Bristol-Myers Squibb Company.
Based on Application, the market is segmented into Ischemic Stroke and Hemorrhagic Stroke. Based on Type, the market is segmented into Diagnostics and Therapeutics. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, B. Braun Melsungen Ag, Boston Scientific Corporation, Cardinal Health, Inc., Ge Healthcare, Glaxosmithkline Plc, Medtronic Plc., Siemens Aktiengesellschaft, Merck & Co., Inc., and Bristol-Myers Squibb Company.
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Stroke Management Market, by Type
1.4.2 Asia Pacific Stroke Management Market, by Application
1.4.3 Asia Pacific Stroke Management Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Players Outlook for the Market
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. ASIA PACIFIC STROKE MANAGEMENT MARKET BY TYPE
3.1.1 Asia Pacific Diagnostics Stroke Management Market by Country
3.1.1.1 Asia Pacific Stroke Management Market by Diagnostics Type
3.1.1.1.1 Asia Pacific Stroke Management Computed Tomography Scan (CT Scan) Market by Country
3.1.1.1.2 Asia Pacific Stroke Management Magnetic Resonance Imaging (MRI) Market by Country
3.1.1.1.3 Asia Pacific Stroke Management Echocardiography Market by Country
3.1.1.1.4 Asia Pacific Stroke Management Carotid Ultrasound Market by Country
3.1.1.1.5 Asia Pacific Stroke Management Cerebral Angiography Market by Country
3.1.1.1.6 Asia Pacific Stroke Management Electrocardiography Market by Country
3.1.1.1.7 Asia Pacific Other Diagnostics Type Stroke Management Market by Country
3.1.2 Asia Pacific Therapeutics Stroke Management Market by Country
3.1.2.1 Asia Pacific Stroke Management Market by Therapeutics Type
3.1.2.1.1 Asia Pacific Tissue Plasminogen Activator Stroke Management Market by Country
3.1.2.1.2 Asia Pacific Anticoagulant Stroke Management Market by Country
3.1.2.1.3 Asia Pacific Antiplatelet Stroke Management Market by Country
3.1.2.1.4 Asia Pacific Other Therapeutics Type Stroke Management Market by Country
CHAPTER 4. ASIA PACIFIC STROKE MANAGEMENT MARKET BY APPLICATION
4.1.1 Asia Pacific Ischemic Stroke Management Market by Country
4.1.2 Asia Pacific Haemorrhagic Stroke Management Market by Country
CHAPTER 5. ASIA PACIFIC STROKE MANAGEMENT MARKET BY COUNTRY
5.1 China Stroke Management Market
5.1.1 China Stroke Management Market by Type
5.1.1.1 China Stroke Management Market by Diagnostics Type
5.1.1.2 China Stroke Management Market by Therapeutics Type
5.1.2 China Stroke Management Market by Application
5.2 Japan Stroke Management Market
5.2.1 Japan Stroke Management Market by Type
5.2.1.1 Japan Stroke Management Market by Diagnostics Type
5.2.1.2 Japan Stroke Management Market by Therapeutics Type
5.2.2 Japan Stroke Management Market by Application
5.3 India Stroke Management Market
5.3.1 India Stroke Management Market by Type
5.3.1.1 India Stroke Management Market by Diagnostics Type
5.3.1.2 India Stroke Management Market by Therapeutics Type
5.3.2 India Stroke Management Market by Application
5.4 South Korea Stroke Management Market
5.4.1 South Korea Stroke Management Market by Type
5.4.1.1 South Korea Stroke Management Market by Diagnostics Type
5.4.1.2 South Korea Stroke Management Market by Therapeutics Type
5.4.2 South Korea Stroke Management Market by Application
5.5 Singapore Stroke Management Market
5.5.1 Singapore Stroke Management Market by Type
5.5.1.1 Singapore Stroke Management Market by Diagnostics Type
5.5.1.2 Singapore Stroke Management Market by Therapeutics Type
5.5.2 Singapore Stroke Management Market by Application
5.6 Malaysia Stroke Management Market
5.6.1 Malaysia Stroke Management Market by Type
5.6.1.1 Malaysia Stroke Management Market by Diagnostics Type
5.6.1.2 Malaysia Stroke Management Market by Therapeutics Type
5.6.2 Malaysia Stroke Management Market by Application
5.7 Rest of Asia Pacific Stroke Management Market
5.7.1 Rest of Asia Pacific Stroke Management Market by Type
5.7.1.1 Rest of Asia Pacific Stroke Management Market by Diagnostics Type
5.7.1.2 Rest of Asia Pacific Stroke Management Market by Therapeutics Type
5.7.2 Rest of Asia Pacific Stroke Management Market by Application
CHAPTER 6. COMPANY PROFILES
6.1 B. Braun Melsungen AG.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental Analysis
6.1.4 Research & Development Expense
6.2 ABBOTT
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional & Segmental Analysis
6.2.4 Research & Development Expense
6.3 Cardinal Health
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental Analysis
6.4 Medtronic Plc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 General Electric (GE) (GE Healthcare)
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 Siemens Healthineers
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental Analysis
6.6.4 Research & Development Expense
6.7 Bristol-Myers Squibb
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.8 Merck & Company Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental Analysis
6.8.4 Research & Development Expense
6.9 Glaxosmithkline Plc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental Analysis
6.9.4 Research & Development Expense
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Stroke Management Market, by Type
1.4.2 Asia Pacific Stroke Management Market, by Application
1.4.3 Asia Pacific Stroke Management Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Players Outlook for the Market
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. ASIA PACIFIC STROKE MANAGEMENT MARKET BY TYPE
3.1.1 Asia Pacific Diagnostics Stroke Management Market by Country
3.1.1.1 Asia Pacific Stroke Management Market by Diagnostics Type
3.1.1.1.1 Asia Pacific Stroke Management Computed Tomography Scan (CT Scan) Market by Country
3.1.1.1.2 Asia Pacific Stroke Management Magnetic Resonance Imaging (MRI) Market by Country
3.1.1.1.3 Asia Pacific Stroke Management Echocardiography Market by Country
3.1.1.1.4 Asia Pacific Stroke Management Carotid Ultrasound Market by Country
3.1.1.1.5 Asia Pacific Stroke Management Cerebral Angiography Market by Country
3.1.1.1.6 Asia Pacific Stroke Management Electrocardiography Market by Country
3.1.1.1.7 Asia Pacific Other Diagnostics Type Stroke Management Market by Country
3.1.2 Asia Pacific Therapeutics Stroke Management Market by Country
3.1.2.1 Asia Pacific Stroke Management Market by Therapeutics Type
3.1.2.1.1 Asia Pacific Tissue Plasminogen Activator Stroke Management Market by Country
3.1.2.1.2 Asia Pacific Anticoagulant Stroke Management Market by Country
3.1.2.1.3 Asia Pacific Antiplatelet Stroke Management Market by Country
3.1.2.1.4 Asia Pacific Other Therapeutics Type Stroke Management Market by Country
CHAPTER 4. ASIA PACIFIC STROKE MANAGEMENT MARKET BY APPLICATION
4.1.1 Asia Pacific Ischemic Stroke Management Market by Country
4.1.2 Asia Pacific Haemorrhagic Stroke Management Market by Country
CHAPTER 5. ASIA PACIFIC STROKE MANAGEMENT MARKET BY COUNTRY
5.1 China Stroke Management Market
5.1.1 China Stroke Management Market by Type
5.1.1.1 China Stroke Management Market by Diagnostics Type
5.1.1.2 China Stroke Management Market by Therapeutics Type
5.1.2 China Stroke Management Market by Application
5.2 Japan Stroke Management Market
5.2.1 Japan Stroke Management Market by Type
5.2.1.1 Japan Stroke Management Market by Diagnostics Type
5.2.1.2 Japan Stroke Management Market by Therapeutics Type
5.2.2 Japan Stroke Management Market by Application
5.3 India Stroke Management Market
5.3.1 India Stroke Management Market by Type
5.3.1.1 India Stroke Management Market by Diagnostics Type
5.3.1.2 India Stroke Management Market by Therapeutics Type
5.3.2 India Stroke Management Market by Application
5.4 South Korea Stroke Management Market
5.4.1 South Korea Stroke Management Market by Type
5.4.1.1 South Korea Stroke Management Market by Diagnostics Type
5.4.1.2 South Korea Stroke Management Market by Therapeutics Type
5.4.2 South Korea Stroke Management Market by Application
5.5 Singapore Stroke Management Market
5.5.1 Singapore Stroke Management Market by Type
5.5.1.1 Singapore Stroke Management Market by Diagnostics Type
5.5.1.2 Singapore Stroke Management Market by Therapeutics Type
5.5.2 Singapore Stroke Management Market by Application
5.6 Malaysia Stroke Management Market
5.6.1 Malaysia Stroke Management Market by Type
5.6.1.1 Malaysia Stroke Management Market by Diagnostics Type
5.6.1.2 Malaysia Stroke Management Market by Therapeutics Type
5.6.2 Malaysia Stroke Management Market by Application
5.7 Rest of Asia Pacific Stroke Management Market
5.7.1 Rest of Asia Pacific Stroke Management Market by Type
5.7.1.1 Rest of Asia Pacific Stroke Management Market by Diagnostics Type
5.7.1.2 Rest of Asia Pacific Stroke Management Market by Therapeutics Type
5.7.2 Rest of Asia Pacific Stroke Management Market by Application
CHAPTER 6. COMPANY PROFILES
6.1 B. Braun Melsungen AG.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental Analysis
6.1.4 Research & Development Expense
6.2 ABBOTT
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional & Segmental Analysis
6.2.4 Research & Development Expense
6.3 Cardinal Health
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental Analysis
6.4 Medtronic Plc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 General Electric (GE) (GE Healthcare)
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 Siemens Healthineers
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental Analysis
6.6.4 Research & Development Expense
6.7 Bristol-Myers Squibb
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.8 Merck & Company Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental Analysis
6.8.4 Research & Development Expense
6.9 Glaxosmithkline Plc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental Analysis
6.9.4 Research & Development Expense
LIST OF TABLES
TABLE 1 ASIA PACIFIC STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 2 ASIA PACIFIC STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 3 ASIA PACIFIC STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 4 ASIA PACIFIC STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 5 ASIA PACIFIC DIAGNOSTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 6 ASIA PACIFIC DIAGNOSTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 7 ASIA PACIFIC STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 8 ASIA PACIFIC STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 9 ASIA PACIFIC STROKE MANAGEMENT COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 10 ASIA PACIFIC STROKE MANAGEMENT COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 11 ASIA PACIFIC STROKE MANAGEMENT MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 12 ASIA PACIFIC STROKE MANAGEMENT MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 13 ASIA PACIFIC STROKE MANAGEMENT ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 14 ASIA PACIFIC STROKE MANAGEMENT ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 15 ASIA PACIFIC STROKE MANAGEMENT CAROTID ULTRASOUND MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 16 ASIA PACIFIC STROKE MANAGEMENT CAROTID ULTRASOUND MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 17 ASIA PACIFIC STROKE MANAGEMENT CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 18 ASIA PACIFIC STROKE MANAGEMENT CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 19 ASIA PACIFIC STROKE MANAGEMENT ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 20 ASIA PACIFIC STROKE MANAGEMENT ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 21 ASIA PACIFIC OTHER DIAGNOSTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 22 ASIA PACIFIC OTHER DIAGNOSTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 23 ASIA PACIFIC THERAPEUTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 24 ASIA PACIFIC THERAPEUTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 25 ASIA PACIFIC STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 26 ASIA PACIFIC STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 27 ASIA PACIFIC TISSUE PLASMINOGEN ACTIVATOR STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 28 ASIA PACIFIC TISSUE PLASMINOGEN ACTIVATOR STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 29 ASIA PACIFIC ANTICOAGULANT STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 30 ASIA PACIFIC ANTICOAGULANT STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 31 ASIA PACIFIC ANTIPLATELET STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 32 ASIA PACIFIC ANTIPLATELET STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 33 ASIA PACIFIC OTHER THERAPEUTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 34 ASIA PACIFIC OTHER THERAPEUTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 35 ASIA PACIFIC STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 36 ASIA PACIFIC STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 37 ASIA PACIFIC ISCHEMIC STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 38 ASIA PACIFIC ISCHEMIC STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 39 ASIA PACIFIC HAEMORRHAGIC STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 40 ASIA PACIFIC HAEMORRHAGIC STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 41 ASIA PACIFIC STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 42 ASIA PACIFIC STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 43 CHINA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 44 CHINA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 45 CHINA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 46 CHINA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 47 CHINA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 48 CHINA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 49 CHINA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 50 CHINA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 51 CHINA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 52 CHINA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 53 JAPAN STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 54 JAPAN STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 55 JAPAN STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 56 JAPAN STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 57 JAPAN STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 58 JAPAN STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 59 JAPAN STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 60 JAPAN STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 61 JAPAN STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 62 JAPAN STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 63 INDIA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 64 INDIA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 65 INDIA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 66 INDIA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 67 INDIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 68 INDIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 69 INDIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 70 INDIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 71 INDIA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 72 INDIA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 73 SOUTH KOREA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 74 SOUTH KOREA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 75 SOUTH KOREA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 76 SOUTH KOREA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 77 SOUTH KOREA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 78 SOUTH KOREA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 79 SOUTH KOREA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 80 SOUTH KOREA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 81 SOUTH KOREA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 82 SOUTH KOREA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 83 SINGAPORE STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 84 SINGAPORE STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 85 SINGAPORE STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 86 SINGAPORE STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 87 SINGAPORE STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 88 SINGAPORE STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 89 SINGAPORE STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 90 SINGAPORE STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 91 SINGAPORE STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 92 SINGAPORE STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 93 MALAYSIA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 94 MALAYSIA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 95 MALAYSIA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 96 MALAYSIA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 97 MALAYSIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 98 MALAYSIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 99 MALAYSIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 100 MALAYSIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 101 MALAYSIA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 102 MALAYSIA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 103 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 104 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 105 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 106 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 107 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 108 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 109 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 110 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 111 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 112 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 113 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 114 KEY INFORMATION – ABBOTT
TABLE 115 KEY INFORMATION – CARDINAL HEALTH
TABLE 116 BUSINESS SEGMENT – CARDINAL HEALTH
TABLE 117 KEY INFORMATION – MEDTRONIC PLC
TABLE 118 KEY INFORMATION – MEDTRONIC
TABLE 119 KEY INFORMATION – GENERAL ELECTRIC (GE)
TABLE 120 KEY INFORMATION - SIEMENS HEALTHINEERS
TABLE 121 KEY INFORMATION - BRISTOL-MYERS SQUIBB
TABLE 122 KEY INFORMATION - MERCK & COMPANY INC.
TABLE 123 KEY INFORMATION - GLAXOSMITHKLINE PLC.
TABLE 1 ASIA PACIFIC STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 2 ASIA PACIFIC STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 3 ASIA PACIFIC STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 4 ASIA PACIFIC STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 5 ASIA PACIFIC DIAGNOSTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 6 ASIA PACIFIC DIAGNOSTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 7 ASIA PACIFIC STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 8 ASIA PACIFIC STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 9 ASIA PACIFIC STROKE MANAGEMENT COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 10 ASIA PACIFIC STROKE MANAGEMENT COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 11 ASIA PACIFIC STROKE MANAGEMENT MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 12 ASIA PACIFIC STROKE MANAGEMENT MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 13 ASIA PACIFIC STROKE MANAGEMENT ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 14 ASIA PACIFIC STROKE MANAGEMENT ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 15 ASIA PACIFIC STROKE MANAGEMENT CAROTID ULTRASOUND MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 16 ASIA PACIFIC STROKE MANAGEMENT CAROTID ULTRASOUND MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 17 ASIA PACIFIC STROKE MANAGEMENT CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 18 ASIA PACIFIC STROKE MANAGEMENT CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 19 ASIA PACIFIC STROKE MANAGEMENT ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 20 ASIA PACIFIC STROKE MANAGEMENT ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 21 ASIA PACIFIC OTHER DIAGNOSTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 22 ASIA PACIFIC OTHER DIAGNOSTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 23 ASIA PACIFIC THERAPEUTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 24 ASIA PACIFIC THERAPEUTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 25 ASIA PACIFIC STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 26 ASIA PACIFIC STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 27 ASIA PACIFIC TISSUE PLASMINOGEN ACTIVATOR STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 28 ASIA PACIFIC TISSUE PLASMINOGEN ACTIVATOR STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 29 ASIA PACIFIC ANTICOAGULANT STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 30 ASIA PACIFIC ANTICOAGULANT STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 31 ASIA PACIFIC ANTIPLATELET STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 32 ASIA PACIFIC ANTIPLATELET STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 33 ASIA PACIFIC OTHER THERAPEUTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 34 ASIA PACIFIC OTHER THERAPEUTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 35 ASIA PACIFIC STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 36 ASIA PACIFIC STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 37 ASIA PACIFIC ISCHEMIC STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 38 ASIA PACIFIC ISCHEMIC STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 39 ASIA PACIFIC HAEMORRHAGIC STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 40 ASIA PACIFIC HAEMORRHAGIC STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 41 ASIA PACIFIC STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 42 ASIA PACIFIC STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 43 CHINA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 44 CHINA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 45 CHINA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 46 CHINA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 47 CHINA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 48 CHINA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 49 CHINA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 50 CHINA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 51 CHINA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 52 CHINA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 53 JAPAN STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 54 JAPAN STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 55 JAPAN STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 56 JAPAN STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 57 JAPAN STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 58 JAPAN STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 59 JAPAN STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 60 JAPAN STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 61 JAPAN STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 62 JAPAN STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 63 INDIA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 64 INDIA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 65 INDIA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 66 INDIA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 67 INDIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 68 INDIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 69 INDIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 70 INDIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 71 INDIA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 72 INDIA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 73 SOUTH KOREA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 74 SOUTH KOREA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 75 SOUTH KOREA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 76 SOUTH KOREA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 77 SOUTH KOREA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 78 SOUTH KOREA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 79 SOUTH KOREA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 80 SOUTH KOREA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 81 SOUTH KOREA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 82 SOUTH KOREA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 83 SINGAPORE STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 84 SINGAPORE STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 85 SINGAPORE STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 86 SINGAPORE STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 87 SINGAPORE STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 88 SINGAPORE STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 89 SINGAPORE STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 90 SINGAPORE STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 91 SINGAPORE STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 92 SINGAPORE STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 93 MALAYSIA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 94 MALAYSIA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 95 MALAYSIA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 96 MALAYSIA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 97 MALAYSIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 98 MALAYSIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 99 MALAYSIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 100 MALAYSIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 101 MALAYSIA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 102 MALAYSIA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 103 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 104 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 105 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 106 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 107 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 108 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 109 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 110 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 111 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 112 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 113 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 114 KEY INFORMATION – ABBOTT
TABLE 115 KEY INFORMATION – CARDINAL HEALTH
TABLE 116 BUSINESS SEGMENT – CARDINAL HEALTH
TABLE 117 KEY INFORMATION – MEDTRONIC PLC
TABLE 118 KEY INFORMATION – MEDTRONIC
TABLE 119 KEY INFORMATION – GENERAL ELECTRIC (GE)
TABLE 120 KEY INFORMATION - SIEMENS HEALTHINEERS
TABLE 121 KEY INFORMATION - BRISTOL-MYERS SQUIBB
TABLE 122 KEY INFORMATION - MERCK & COMPANY INC.
TABLE 123 KEY INFORMATION - GLAXOSMITHKLINE PLC.
